Hospitals / providers

Cancer Progress Still Depends on Your Postcode

Resistant hypertension may need a diagnostic revolution, not just another drug

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.

The Biomarker Test Cannot Wait Until Relapse

Cancer Treatment Is an Endurance Event. Stop Waiting for Patients to Lose Function.

Harlem’s Legionnaires’ Outbreak Was Not Just in the Air. It Was in the System.

When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
